Big Pharma Split (TSX:PRM) Growth Rank : 1 (As of Jun. 06, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Growth Rank?

Big Pharma Split has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Competitive Comparison of Big Pharma Split's Growth Rank

For the Asset Management subindustry, Big Pharma Split's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Big Pharma Split's Growth Rank Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, Big Pharma Split's Growth Rank distribution charts can be found below:

* The bar in red indicates where Big Pharma Split's Growth Rank falls into.

Big Pharma Split Growth Rank Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split (TSX:PRM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

PRM.PR.A.PFD:Canada

Address

610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5

Website

https://www.harvestportfolios.com

Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Executives

Michael Kovacs

Director, Senior Officer